Literature DB >> 27278718

Urinary cotinine levels of electronic cigarette (e-cigarette) users.

Gülşen Göney1, İsmet Çok1, Uğur Tamer2, Sema Burgaz1, Tijen Şengezer3.   

Abstract

The popularity of electronic cigarettes (e-cigarettes) is rapidly increasing in many countries. These devices are designed to imitate regular cigarettes, delivering nicotine via inhalation without combusting tobacco but currently, there is a lack of scientific evidence on the presence or absence of nicotine exposure. Such research relies on evidence from e-cigarette users urine samples. In this study, we aimed to determine the levels and compare the amount of nicotine to which e-cigarette users, cigarette smokers and passive smokers are exposed. Therefore, urine samples were collected from e-cigarette users, cigarette smokers, passive smokers, and healthy nonsmokers. The urinary cotinine levels of the subjects were determined using gas chromatography-mass spectrometry. The mean (±SD) urinary cotinine levels were determined as 1755 ± 1848 ng/g creatinine for 32 e-cigarette users, 1720 ± 1335 ng/g creatinine for 33 cigarette smokers and 81.42 ± 97.90 ng/g creatinine for 33 passive smokers. A significant difference has been found between cotinine levels of e-cigarette users and passive smokers (p < 0.05). There were no statistically significant differences between e-cigarette users and cigarette smokers (p > 0.05). This is a seminal study to demonstrate the e-cigarette users are exposed to nicotine as much as cigarette smokers.

Entities:  

Keywords:  Cotinine; GC–MS; Turkey; e-cigarette; urine

Mesh:

Substances:

Year:  2016        PMID: 27278718     DOI: 10.3109/15376516.2016.1144127

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  8 in total

1.  Nicotine Delivery of E-Cigarettes.

Authors:  Evrim Eylem Akpınar
Journal:  Turk Thorac J       Date:  2020-01-01

2.  Serum Concentrations of Cotinine and Trans-3'-Hydroxycotinine in US Adults: Results From Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health Study.

Authors:  Connie S Sosnoff; Kevin Caron; J Ricky Akins; Kristin Dortch; Ronald E Hunter; Brittany N Pine; June Feng; Benjamin C Blount; Yao Li; Dana M van Bemmel; Heather L Kimmel; Kathryn C Edwards; Maciej L Goniewicz; Dorothy K Hatsukami; B Rey de Castro; John T Bernert; Stephen Arnstein; Nicolette Borek; Ying Deng-Bryant; Elena Mishina; Charles Lawrence; Andrew Hyland; Stephen S Hecht; Kevin P Conway; James L Pirkle; Lanqing Wang
Journal:  Nicotine Tob Res       Date:  2022-03-26       Impact factor: 4.244

3.  Effect of Second-Hand Smoke Exposure on Establishing Urinary Cotinine-Based Optimal Cut-Off Values for Smoking Status Classification in Korean Adults.

Authors:  Hyun-Seung Lee; Ji-Hyun Cho; Young-Jin Lee; Do-Sim Park
Journal:  Int J Environ Res Public Health       Date:  2022-06-29       Impact factor: 4.614

Review 4.  Recent updates on biomarkers of exposure and systemic toxicity in e-cigarette users and EVALI.

Authors:  Samantha R McDonough; Irfan Rahman; Isaac Kirubakaran Sundar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-01-27       Impact factor: 5.464

Review 5.  E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure.

Authors:  Elise E DeVito; Suchitra Krishnan-Sarin
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

6.  Association of electronic cigarette exposure with serum uric acid level and hyperuricemia: 2016-2017 Korea National Health and Nutritional Examination Survey.

Authors:  Taeyun Kim; Yunkyung Kim; Jihun Kang
Journal:  PLoS One       Date:  2021-03-01       Impact factor: 3.240

7.  Special issue on electronic cigarettes.

Authors:  Rakesh Dixit
Journal:  Toxicol Mech Methods       Date:  2016-07       Impact factor: 2.987

8.  Differences between the effects of conventional cigarettes, e-cigarettes and dual product use on urine cotinine levels.

Authors:  Myung-Bae Park; Jung-Kyu Choi
Journal:  Tob Induc Dis       Date:  2019-02-18       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.